Depressive Disorder and Anxiety Disorders
11
1
1
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (11)
The Impact of Melatonin Lotion on Sleep and Mental Health
To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.
A First Time in Human Study of GSK586529 in Healthy Volunteers
First Study in Humans With GSK424887
First Study in Humans With GSK206136
Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers
First Time in Human Study
A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers
Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic
PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients
Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males